Stanford University
Showing 61-80 of 141 Results
-
Michael Kozal
Professor of Medicine (Infectious Diseases)
BioDr. Kozal is a Professor of Medicine in the Division of Infectious Diseases and Geographic Medicine. He previously served as Senior Associate Dean for Veteran Affairs at Stanford School of Medicine and Chief of Staff at VA Palo Alto Health Care System. Prior to coming to Stanford, he was a Professor of Medicine at Yale University School of Medicine and served as Associate Dean for Veteran Affairs at Yale University School of Medicine and the Chief of Staff at VA Connecticut Healthcare System.
Dr. Kozal is a translational researcher who has focused his research career on three areas: 1) investigating the genetic determinants of HIV and HCV drug resistance, 2) the development of new molecular methods to detect viral mutations, and 3) HIV and HCV clinical trials involving new drugs and diagnostic technology. Dr. Kozal is an expert in microarray and deep sequencing technology receiving patents for his work in genotyping. Dr. Kozal previously directed the Yale HIV Clinical Trials Group and has more than 20 years of experience in running clinical trials, serving as the principal investigator or site investigator on >40 HIV and Hepatitis C trials. He has served on multiple VA and NIH/NCI review panels and was a member of the DHHS/NIH Panel on Antiretroviral Guidelines for Adults and Adolescents from 2015-2024. -
Max Lamparth
Postdoctoral Scholar, Infectious Diseases
BioMax is a postdoctoral fellow at the Center for International Security and Cooperation, the Stanford Center for AI Safety, the Stanford Existential Risks Initiative, and the Brainstorm Lab at the Department of Psychiatry and Behavioral Sciences at Stanford University. He is advised by Prof. Clark Barrett, Prof. Steve Luby, and Prof. Paul Edwards.
With his research, he wants to make AI systems more secure and safe to use. Specifically, he is focussing on improving the ethical behavior of language models, making their inner workings more interpretable, and increasing their robustness against misuse.
Max received his Ph.D. in August 2023 from the School of Natural Sciences at the Technical University of Munich and previously a B.Sc. and M.Sc. in Physics from the Ruprecht Karl University of Heidelberg. -
Vivian Levy
Clinical Associate Professor (Affiliated), Medicine - Med/Infectious Diseases
Staff, Medicine - Med/Infectious DiseasesBioVivian Levy is Chief of Infectious Diseases at San Mateo Medical Center (SMMC), San Mateo County’s safety net hospital and clinic system in northern California since 2015 and the County’s STD Control Officer since 2006. San Mateo County has 760,000 persons and connects the urban centers of San Francisco and San Jose, California.
Dr. Levy leads Stanford’s Internal Medicine outpatient Infectious Diseases rotation for Internal Medicine residents. She has served 2 terms as president of the California STD/HIV Controllers Association. From 2004-2008, she was the medical officer for the Chemoprophylaxis for HIV prevention in men study in Lima, Peru.
In 2020, she was the San Mateo Medical Center site investigator for the Expanded Access Treatment Protocol: Remdesivir for the Treatment of SARS-CoV2 Infection. She began SMMC patient recruitment for Stanford outpatient COVID studies July 2020 with the goal of increasing historically underrepresented populations participation and access in COVID outpatient treatment trials.
She has an undergraduate degree from Brown University (1989,) an MD from Rush University Medical College in Chicago (1994,) completed internship in Internal Medicine at Cook County Hospital in Chicago (1995) Internal Medicine residency at Northwestern University (1997) and an Infectious Diseases and Geographic Medicine fellowship at Stanford University (2000-2004.) -
Nathan Lo
Assistant Professor of Medicine (Infectious Diseases) and, by courtesy, of Epidemiology and Population Health
Current Research and Scholarly InterestsOur research group is interested in studying the transmission of infectious diseases and impact of public health interventions with an ultimate goal of informing public health policy. We study a diverse set of pathogens, both domestically and internationally, including vaccine-preventable infections (including COVID-19) and neglected parasitic diseases (such as schistosomiasis). Our group applies diverse computational methodologies, including tools from fields of epidemiology, mathematical and statistical modeling, simulation, and policy analysis.
A large emphasis of our work is translating scientific evidence into public health policy. Our track record includes multiple studies that have changed policy in the fields of neglected parasitic diseases and COVID-19. We work closely with policy organizations like the World Health Organization and the California Department of Public Health. Nathan was the lead writer of the World Health Organization guidelines on schistosomiasis (2022) and strongyloidiasis (2024).
Our current research focuses on the following areas:
(1) Vaccine-preventable infectious diseases (including COVID-19) in the United States, with a focus on studying vaccines and transmission dynamics
(2) Public health strategies for control and elimination of globally important neglected infectious diseases, such as helminths infections (schistosomiasis, strongyloidiasis) and typhoid fever
Our currently funded NIH projects include:
(1) Real-time predictive modeling for public health departments to control infectious diseases (DP2 AI170485)
(2) Precision mapping of Schistosoma mansoni risk for targeted public health control and elimination (R01 AI179771)
Hiring
We are seeking to fill multiple research positions at all levels. Candidates interested in working on computational public health research related to infectious diseases with a strong quantitative background are highly encouraged to apply. If you an interested, please submit a cover letter, CV, and names of two references to Nathan.Lo@stanford.edu. -
Stephen Luby
Lucy Becker Professor of Medicine, Senior Fellow at the Woods Institute for the Environment, Freeman Spogli Institute for International Studies and Professor, by courtesy, of Epidemiology and Population Health
Current Research and Scholarly InterestsDr. Luby’s research interests include identifying and interrupting pathways of infectious disease transmission in low income countries.
-
Natalia Medvedeva
Clinical Assistant Professor, Medicine - Infectious Diseases
BioDr Natalia Medvedeva specializes in the treatment of infectious diseases. She has a special interest in antimicrobial stewardship and medical education.
-
Thomas Charles Merigan M.D.
George E. and Lucy Becker Professor of Medicine, Emeritus
Current Research and Scholarly InterestsI am now emeritus and only participate in university activities through advising my former trainees who have joined the faculty.
